STOCKTALK CENTRAL SPECIAL ALERT
NEWS ALERT!
IBXG Group, Inc. (OTCBB: IBXG) Near Term Price Projection: $.29
SHARES OUTSTANDING: 65 million
APPROX. FLOAT: 37 million
Near Term Price Proj.: $.29

A Few Reasons To Own IBXG
  1. IBXG is an emerging growth company in the trillion-dollar healthcare industry.
  2. IBXG is coming off its fourth quarter in a row of increasing revenues and its second consecutive profitable quarter. IBXG experienced a 50% gain in third quarter revenue.
  3. IBXG estimated EPS for all of 2002 is estimated to be $.01 per share.
  4. IBXG is currently cash flow positive. IBXG is making acquisitions and expanding its infrastructure while vigorously pursuing the Marketing Plan.
  5. IBXG is a results-oriented company with three integrated divisions - Healthcare Transaction Services, Physical Therapy & Occupational Medicine, and Technology/Information Services.
  6. IBXG has established a strong market niche in the area of Healthcare Transaction Services.
  7. IBXG recently began managing its largest receivables management project ever totaling $39 million from Intracoastal Health Systems, Inc. of West Palm Beach, Florida.
  8. IBXG has implemented a clear-cut strategic plan to expand its capabilities in the area of Physical Therapy and Occupational Medicine.
  9. IBXG has developed and recently commenced marketing an innovative web-based inventory management application for the $1.5 billion durable medical equipment (DME) industry.
  10. IBXG has developed and deployed a proprietary online consumer medical records service throughout the U.S. The technology is being utilized by several affinity groups, including one of the largest credit card companies in the world.
  11. IBXG's internal compliance program has been certified as meeting all current requirements of the Federal Health Insurance Portability and Accountability Act (HIPAA).
UPDATE

Great News! IBXG Expands its Services and Validates Guidance for one of its Core Divisions over the Next 12 Months.

As Stated in Today's PR (read below):

"The fee income from this contract will support the overall guidance for iBX's Florida HealthSource division at $6 million during the next 12 months."

It's Really Nice to see that not only is IBXG Expanding it Clinics Across All of Florida, but it is also Expanding its Services throughout it Divisions.

What Does This Mean? It's rather simple... to us we see Additional Fee Business in a rapidly Growing Business and a CONFIRMATION OF GUIDANCE IN ONE OF IBXG's LARGEST DIVISION'S.

This Equates to Additional Revenues To IBXG and Furthermore Helps IBXG Brand itself in their core South Florida Market.

As Best Stated By IBXG's CEO In Today's PR:

"This agreement with the pulmonary clinic will provide us with an enormous and previously untapped niche in the healthcare sector..... In addition, this expansion will strengthen the Florida HealthSource brand even further within our core South Florida market."

Hopefully One Day Soon The Market will Recognize IBXG's Possible Potential,

SO, We Continue to make the argument that IBXG still lags its Peers in Valuation.

IN OUR OPINION, AT CURRENT STOCK PRICE LEVELS IBXG APPEARS TO US TO CONTINUE TO BE GROSSLY UNDERVALUED COMPARED TO ITS PEERS, AND WE BELIEVE IS DO FOR A POP TO HIGHER STOCK MARKET VALUATION'S AND HOPEFULLY SOON.

UNDERVALUED AND OVERLOOKED! Perhaps, in our opinion, but only time will tell.

So Keep your EYES OPEN AND GLUED TO THE SCREEN

As We Think MORE PR IS LIKELY FORTHCOMING, and as always,

Watch This Stock Trade.


PRESS RELEASE

IBX GROUP'S FLORIDA HEALTHSOURCE OF PALM BEACH EXPANDS REACH INTO PULMONARY REHABILITATION SECTOR

DEERFIELD BEACH, Fla., Nov. 3, 2003 - Florida HealthSource of Palm Beach, a division of iBX Group, Inc. (OTC Bulletin Board: IBXG), announced today that it has agreed to terms to manage a west Delray Beach, Fla., pulmonary rehabilitation clinic and bring the center into the statewide Florida HealthSource network of physical therapy and rehabilitation clinics.

iBX will initially provide practice management, compliance, transcription and accounts receivables services through its iBX Technologies and MediCompliant Solutions divisions, and will explore the possibility of an ownership interest in the clinic. The fee income from this contract will support the overall guidance for iBX's Florida HealthSource division at $6 million during the next 12 months.

"This agreement with the pulmonary clinic will provide us with an enormous and previously untapped niche in the healthcare sector," said Evan R. Brovenick, president and CEO of iBX. "In addition, this expansion will strengthen the Florida HealthSource brand even further within our core South Florida market."

Pulmonary rehabilitation is indicated for patients with chronic respiratory disease who continue to suffer from decreased lung functioning despite standard medical treatment. Other patients who benefit from pulmonary rehabilitation include those with asthma, bronchitis, emphysema, pneumonia, chest wall diseases, cystic fibrosis, lung cancer, interstitial lung disease and those recovering from thoracic or abdominal surgery and lung transplantation, as well as premature infants and victims of chest trauma.

The growing elderly population, advances in the treatment of premature infants and the environmental impact on diseases such as asthma have prompted a large increase in demand for pulmonary rehabilitation services, according to the American Association for Respiratory Care. The U.S. Bureau of Labor Statistics has projected a 43 percent increase in demand for respiratory therapists from 1998 to 2008.

Florida HealthSource's 18 multi-disciplinary clinics offer a variety of physical therapy, occupational medicine, rehabilitation, pain management, chiropractic care and wellness services in a relaxing, upscale setting. The centers are designed to showcase iBX's menu of technology services for the healthcare industry, including TheraTouch, a programmable, interactive massage device.

Based in Deerfield Beach, Florida, iBX Group Inc. develops and deploys creative, cost-effective methods for integrating financial, administrative and information services for the healthcare industry. iBX is a results-oriented company, consisting of five divisions - iBX Technologies, which enables healthcare organizations to maximize their accounts receivables; Florida HealthSource, a network of physical therapy and wellness centers; MediCompliant Solutions, which ensures medical practices' compliance with today's complex legal requirements; iBX Transcription Services, which offers physicians quick turn-around and Web-accessible progress reports; NursesSTAT, a revolutionary temporary staffing solution. iBX also owns SportshealthNet.com, an interactive Web portal providing patients with comprehensive healthcare information and advice, and increasing physician referrals.

This release is comprised of interrelated information that must be interpreted in the context of all of the information provided and care should be exercised not to consider portions of this release out of context. This release contains certain "forward-looking statements and information" (as defined in the Private Securities Litigation Reform Act of 1995) concerning iBX Group, Inc. that are based on the beliefs of iBX Group, Inc.'s management, as well as assumptions made by and information currently available to iBX Group, Inc. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those risks and uncertainties detailed in iBX's filings with the Securities and Exchange Commission.


VALUATION

A Penny Stock with Multi-Dollar Potential: Trading Today in the Teens, but in our opinion, has Near-Term Potential for Huge Gains. IBXG may be one This Year's BIG surprises, making its current status as an undiscovered stock a rare timing opportunity for investors. Don't overlook this one! We not only consider IBXG an attractive "Emerging Growth Company," in our opinion, but also a "Value Stock" in view of its Revenues and Earnings. We believe that IBXG has targeted a creative niche in a hot sector.

Relative to comparative companies within the Healthcare Sector, IBXG could realize superior growth in business and earnings over the Near- Term period. A grouping of comparable companies within this Sector currently trades at an average price to revenues multiple of 6.19 X. For 2003 it is now estimated that IBXG should generate revenues of about $15 MILLION DOLLARS, and EPS of $0.02 Per Share.

If over the Near-Term IBXG were to trade in the Market Place at a 80% Discount to its Peers, then applying the comparative grouping's price to revenue multiples to IBXG we can arrive at a relative valuation of $.29* per share over the Near-Term.


CONCLUSION

"Patients want to do more of their medical management from home, doctors want to provide care quickly and efficiently, and hospitals and HMO’s want to keep costs down," says Jim Gabler, a research director for GartnerGroup’s Healthcare Industry Research and Advisory Services in Stamford, Conn. "All of this relates to technology, and it’s up to CIO’s to find a better way. People say healthcare revolves around doctors and patient care. Well in the months and years to come, the industry will revolve around technology and the CIO."

Given this climate in healthcare today, in our opinion, IBXG is an undervalued opportunity. IBXG is perfectly positioned to meet the needs of their target market with a strong commitment to their suite of services.

Aggressive investors looking for above-average return potential on a portion of their investment capital should give IBXG a serious look.


OUR ADVERTISEMENT TO YOU

Are you a CEO of a Public Company or the Head of an Investor Relations or Public Relations Firm interested in Advertising your Company, or do you have a Product or Service that you would like Advertised to what we believe is the most Qualified & Largest Permission Based Opt-in Membership in the World, demographically speaking.

Unlike any other Email Marketer in the World, we can Guarantee Your Advertisement to be Opened and Read by over 1 Million of our Membership within 12 Hours of when we start to send Emails. We believe no other Email Marketer in the World can make this claim.

Yes, that’s right Guaranteed and Verified by what we believe is the Most Sophisticated Tracking Software in the World. Don’t be confused with other offers to Send Million’s of Emails as opposed to our offer whereby over 1 Million of our Members actually Open and Read Your Advertisement within 12 Hours of when we start to send emails, and many more thereafter.

We Don’t Come Cheap! We charge a premium for our services. So, only serious inquiries need to reply. If you are interested in learning more about our services, please click here and provide us with your contact information and some detail of what you are looking to advertise. If we are interested one of our representative’s will contact you shortly.


*based on 65 million shares outstanding

Disclaimer:

The purpose of this advertisement is to provide publicity for the advertised company, its products or services. This advertisement is not a solicitation or recommendation to buy, sell or hold securities and does not provide an analysis of the financial position of the company. StockTalk Central, and affiliates (STC), publishes reports providing information on selected companies that STC believes has investment potential. STC is not a registered investment advisor or broker-dealer. The above report is the opinion of STC and is not a guarantee that the target price for the stock will be met or that predicted business results for the company will occur. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. STC accepts no liability for any loss arising from an investor's reliance on or use of this report. An investment in IBXG is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Previously, an affiliate of STC has been compensated five hundred forty-five thousand dollars by the company, and additionally received 14.2 million warrants exercisable into free trading shares of common stock of IBXG at ten cents per share and an additional 1 million warrants exercisable into free trading shares of common stock of IBXG at thirteen cents per share and an additional 2 million warrants exercisable into free trading shares of common stock of IBXG at five cents per share by a third party for the publication and circulation of previous reports, of which all the warrants have been exercised and the stock sold. In addition, IBXG has extended their agreement for the publication and circulation of this report, and an affiliate of STC has been compensated one hundred thousand dollars and received an additional 2 million warrants exercisable into free trading shares of IBXG at ten cents per share by a third party (TFST) and STC and affiliates have no relationship whatsoever to the third party.. STC intends to sell all or a portion of the IBXG stock at or about the time of publication of this report. Subsequently STC may buy or sell shares of IBXG stock in the open market. Since an affiliate of STC has been compensated there is an inherent conflict of interest. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. For further details concerning these risks and uncertainties, see the SEC filings of IBXG including the company's most recent annual and quarterly reports.


You are currently subscribed to Stock Talk Central mailing list as [EMAIL PROTECTED]
To unsubscribe, send a blank email to:
mailto:[EMAIL PROTECTED]

Reply via email to